GlobalCapital Asia, is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Asia EquityAsia IPOs

Harbour BioMed sets ball rolling for Hong Kong IPO

biopharma_stocks_adobe_575x375.jpg

Chinese biotechnology start-up HBM Holdings has filed for approval to float on Hong Kong’s stock exchange.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login